Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease

NCT00252122 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Recruitment was very slow.

Conditions

Sickle Cell Disease

Interventions

DRUG: Ketamine

Sponsor

Children's Hospital of Philadelphia